Literature DB >> 8430052

Acacia-gelatin microencapsulated liposomes: preparation, stability, and release of acetylsalicylic acid.

C Dong1, J A Rogers.   

Abstract

Liposomes of dipalmitoylphosphatidylcholine (DPPC) containing acetylsalicylic acid (ASA) have been microencapsulated by acacia-gelatin using the complex coacervation technique as a potential oral drug delivery system. The encapsulation efficiency of ASA was unaltered by the microencapsulation process. The stability of the microencapsulated liposomes in sodium cholate solutions at pH 5.6 was much greater than the corresponding liposomes. The optimum composition and conditions for stability and ASA release were 3.0% acacia-gelatin and a 1- to 2-hr formaldehyde hardening time. Approximately 25% ASA was released in the first 6 hr from microencapsulated liposomes at 23 degrees C and the kinetics followed matrix-controlled release (Q varies; is directly proportional to t1/2). At 37 degrees C, this increased to 75% released in 30 min followed by a slow constant release, likely due to lowering of the phase transition temperature of DPPC by the acacia-gelatin to near 37 degrees C. At both temperatures, the release from control liposomes was even more rapid. Hardening times of 4 hr and an acacia-gelatin concentration of 5% resulted in a lower stability of liposomes and a faster release of ASA. It is concluded that under appropriate conditions the microencapsulation of liposomes by acacia-gelatin may increase their potential as an oral drug delivery system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430052     DOI: 10.1023/a:1018997602334

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Polymer-encased vesicles derived from dioctadecyldimethylammonium methacrylate.

Authors:  H Fukuda; T Diem; J Stefely; F J Kezdy; S L Regen
Journal:  J Am Chem Soc       Date:  1986-04-01       Impact factor: 15.419

2.  Dermal drug delivery by liposome encapsulation: clinical and electron microscopic studies.

Authors:  M Foldvari; A Gesztes; M Mezei
Journal:  J Microencapsul       Date:  1990 Oct-Dec       Impact factor: 3.142

3.  Preparation of microencapsulated liposomes, II. Systems containing nylon-gelatin and nylon-gelatin-acacia walling material.

Authors:  J R Nixon; V W Yeung
Journal:  J Microencapsul       Date:  1989 Jan-Mar       Impact factor: 3.142

4.  Enzymatically activated microencapsulated liposomes can provide pulsatile drug release.

Authors:  P G Kibat; Y Igari; M A Wheatley; H N Eisen; R Langer
Journal:  FASEB J       Date:  1990-05       Impact factor: 5.191

5.  A two-step model of disintegration kinetics of liposomes in bile salts.

Authors:  M Nagata; T Yotsuyanagi; K Ikeda
Journal:  Chem Pharm Bull (Tokyo)       Date:  1988-04       Impact factor: 1.645

6.  Preparation of microencapsulated liposomes.

Authors:  V W Yeung; J R Nixon
Journal:  J Microencapsul       Date:  1988 Oct-Dec       Impact factor: 3.142

7.  pH sensitization of phospholipid vesicles via complexation with synthetic poly(carboxylic acid)s.

Authors:  D A Tirrell; D Y Takigawa; K Seki
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

8.  A low-viscosity epoxy resin embedding medium for electron microscopy.

Authors:  A R Spurr
Journal:  J Ultrastruct Res       Date:  1969-01

9.  Bile salt-induced disintegration of egg phosphatidylcholine liposomes: a kinetic study based on turbidity changes.

Authors:  M Nagata; T Yotsuyanagi; K Ikeda
Journal:  Chem Pharm Bull (Tokyo)       Date:  1990-05       Impact factor: 1.645

10.  Bile acid structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC.

Authors:  A Roda; A Minutello; M A Angellotti; A Fini
Journal:  J Lipid Res       Date:  1990-08       Impact factor: 5.922

  10 in total
  1 in total

1.  Complex coacervation of lysozyme and heparin: complex characterization and protein stability.

Authors:  Marco van de Weert; Mia Bendix Andersen; Sven Frokjaer
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.